Infectious Diseases 1111 - Infectious Disease Alert - Nov 01, 2007

Target Audience:

This activity is intended for the infectious disease specialist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editors
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Frank Bia, MD, MPH
Professor of Medicine and Laboratory Medicine
Yale University School of Medicine

Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Mary-Louise Scully, MD
Travel and Tropical Medicine Center
Sansum Clinic
Santa Barbara, CA

Michele Barry, MD, FACP
Professor of Medicine and Global Health
Yale University School of Medicine

Associate Editors
Hal B. Jenson, MD
Professor of Pediatrics
Tufts University School of Medicine
Chief Academic Officer
Baystate Medical Center Springfield, MA

Dean L. Winslow, MD, FACP, FIDSA
Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine
Section Editor, HIV


  • Viruses Across the World
  • Micafungin for Invasive Candidiasis
  • The Impact of Prescribing Antibiotics to Children
  • Culture-Negative Prosthetic Joint Infection
  • Cholera Cases: Past, Present, and Future
  • Quadrivalent HPV Vaccine as a Travel Vaccine
  • Updates


  • To discuss the diagnosis and treatment of infectious diseases
  • To present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • To present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • To discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy.

Financial Disclosure:

Infectious Disease Alert's Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker's bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck. Peer reviewer Connie Price, MD, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study. Updates author Carol A. Kemper, MD, FACP and author Mary-Louise Scully, MD report no financial relationships relevant to this field of study. Associate editor Hal B. Jenson, MD is on the speaker's bureau for Merck. Associate editor Dean L. Winslow, MD, FACP, FIDSA serves as a consultant to Siemens Diagnostics, and is on the speaker's bureau for Boehringer-Ingelheim and GSK. Physician editor Frank Bia, MD, MPH is a consultant for Pfizer and Sanofi Pasteur, and receives funds from Johnson & Johnson. Author Michele Barry, MD, FACP receives no funding from any issue related to this commentary. Dr. Barry is a consultant for Ford Foundation and had received funding from Johnson and Johnson and Sanofi-Pasteur.

Copyright 2007 AHC Media. All rights reserved.